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Trypanosomatids are important human 
pathogens that form a basal branch of 
eukaryotes. Their evolutionary history is still 
unclear, as are many aspects of their 
molecular biology. Here we characterize 
essential components required for the 
incorporation of serine and selenocysteine 
into the proteome of Trypanosoma. First, the 
biological function of a putative Trypanosoma
seryl-tRNA synthetase is characterized in
vivo. Secondly, the molecular recognition by 
Trypanosoma seryl-tRNA synthetase of its 
cognate tRNAs is dissected in vitro. The 
cellular distribution of tRNASec is studied, and 
the catalytic constants of its aminoacylation 
are determined. These are found to be 
markedly different from those reported in 
other organisms, indicating that this reaction 
is particularly efficient in trypanosomatids. 
Our functional data are analyzed in the 
context of a new phylogenetic analysis of 
eukaryotic seryl-tRNA synthetases that 
includes Trypanosoma and Leishmania
sequences. Our results show that 
trypanosomatid seryl-tRNA synthetases are 
functionally and evolutionarily more closely 
related to their metazoan homologous 
enzymes than to other eukaryotic enzymes. 
This conclusion is supported by sequence 
synapomorphies that clearly connect 
metazoan and trypanosomatid seryl-tRNA 
synthetases.
The formation of aminoacyl-tRNA, 
catalyzed by aminoacyl-tRNA synthetases 
(ARS), is a crucial step in maintaining the 
fidelity of protein biosynthesis. In order to avoid 
misacylation of non-cognate tRNAs, each 
synthetase recognizes identity elements 
idiosyncratic to their cognate substrates. tRNA 
identity elements can be unique and universally 
distributed, as in the case of the G3:U70 base 
pair presented by all tRNAAla (1,2). On  the other 
hand, the evolutionary constraints imposed by 
the necessity of translation fidelity are not rigid, 
and the set of recognition elements for many 
tRNAs have changed during evolution (1,3). 
Thus, the comparison between sets of tRNA 
recognition elements in extant species could be 
used to estimate their evolutionary or biological 
relatedness.
Here we study the evolution of the serylation 
reaction of tRNASer and tRNASec by 
characterizing this activity in trypanosomatids, a 
group of protozoa normally considered to form a 
basal group within eukaryal (4).  Intriguingly, 
the analysis of the evolutionary history of 
Trypanosoma SerRS, and the determination of 
the identity elements used by this enzyme to 
recognize tRNASer, show that Trypanosoma
SerRSs are closer relatives of metazoan SerRSs 
than plant, fungi, or other protozoan enzymes. 
Seryl-tRNA synthetases (SerRSs) are class II 
ARS that contain the characteristic active site 
domain of this family of enzymes (5,6). In 
addition to this domain, the structures of most 
SerRSs include a coiled-coil domain at the 
amino end of their sequence and, in the case of 
eukaryotic enzymes, a C-terminal extension that 
plays a modest role on protein stability and 
amino acid recognition (7,8). The N-terminal 
coiled-coil domain is essential for the 
recognition of the elbow and, especially, the 
long variable loop of tRNASer (9,10).
Studies of the recognition modes between 
SerRS and tRNASer from different kingdoms of 
life have shown that some, but not all, tRNASer
identity determinants have been conserved 
during evolution (for a review see (11)), and that 
different  recognition modes exist. Thus, in 
bacteria and Saccharomyces cerevisiae the 
specific charging of tRNASer depends on the 
recognition of some base pairs in the acceptor 
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stem, but not of the discriminator base at 
position 73 (12-14). In these cases the sequence 
of the variable loop is also crucial. The 
crystallographic structures of T. thermophilus
SerRS complexed with  tRNASer, confirm these 
observations (15,16).
A second type of recognition mode, seen in 
archaeal and human SerRS, is characterized by 
the crucial role of the discriminator base (17-19). 
In these cases the sequence of the variable loop 
is not important, but its size and orientation is 
fundamental for the interaction with the enzyme 
(20,21). The main common features between the 
bacterial and eukaryotic recognition strategies 
are the importance of the variable loop and the 
dispensable character of the anticodon stem-
loop.
Finally, a third type of tRNASer recognition is 
seen in the SerRSs of methanogenic archaea, 
which use a idiosyncratic N-terminal domain to 
recognize the acceptor stem and the variable 
loop of their tRNA substrates (22). These 
unusual enzymes are also sensitive to the 
discriminator base position of their cognate 
tRNAs (23). 
SerRS also aminoacylates tRNASec with 
serine, as the first step for the incorporation of 
selenocysteine into proteins. Components of the 
selenocysteine insertion machinery have been 
identified by computational methods in species 
of the three branches of the tree of life. Recently 
some of these components have also been 
identified in trypanosomatids, and the existence 
of a tRNASec in these organisms has been 
verified (24). 
The serylation reaction of tRNASec has been 
characterized in detail in E. coli and Homo
sapiens (25,26), but the system has not been 
characterized in protozoans or other basal 
eukaryotes. In H. sapiens and E. coli, tRNASec
transcripts have been described as being, 
respectively, 10 and 100 fold less efficient 
substrates for SerRS than tRNASer. It has been 
proposed that this difference is caused by the 
unique structure of tRNASec (26). 
Here we report the first characterization of 
the serylation of tRNASec in trypanosomatids.
We confirm the expression of tRNASec in 
Trypanosoma brucei and  show that, unlike most 
trypanosomal tRNAs, it is exclusively localized 
in the cytosol. Furthermore we characterize its 
aminoacylation with serine by Trypanosoma
cruzi SerRS. We show that the aminoacylation 
constants of tRNASec in Trypanosoma differ 
substantially from those reported in other 
organisms, suggesting that kinetic differences in 
the serylation activity of tRNASec may be 
species-specific, and that regulatory strategies 
may exist based on the efficiency of serine-
tRNASec synthesis. 
EXPERIMENTAL PROCEDURES 
Materials - Oligonucleotides were 
synthesized by Sigma-Genosys. L-[3H] serine 
and HisTrap nickel columns were from 
Amersham Biosciences. Restriction enzymes 
were from New England Biolabs, Pfu Ultra 
DNA polymerase was from Stratagene and 
vector pQE-70 from Quiagen. Novablue cells 
were from Novagen. T. cruzi genomic DNA was 
a gift from Dr. P. Bonay (Universidad Autónoma 
de Madrid, Spain). 
RNAi-mediated ablation of SerRS - RNAi-
mediated ablation of the T. brucei SerRS was 
performed using stem loop constructs containing 
the puromycine resistance gene as described 
(27). As an insert we used a 498 bp fragment 
(nucleotides 1 to 498) of the T. brucei SerRS 
gene. Transfection of T. brucei (strain 29-13), 
selection with antibiotics, cloning and induction 
with tetracycline were done as described (28). 
To analyze the in vivo charging levels of the 
tRNASer and the tRNASec we isolated total RNA 
from uninduced and induced cells by using the 
acid guanidinium isothiocyanate procedure (29). 
The tRNAs remain aminoacylated during this 
procedure due to the low pH employed by the 
method. Subsequently, the RNA samples were 
analyzed on 50 cm long acid urea 
polyacrylamide gels as described (30), which 
can resolve aminoacylated from deacylated 
tRNAs. The gels were analyzed by Northern 
hybridization (31). The following [32P] 5'-end 
labeled oligonucleotides were used as probes: 
5'TGGCGTCACCAGCAGGATTC3' (for the 
tRNASerCGA) and 
5'ACCAGCTGAGCTCATCGTGGC3' (for 
tRNASec).
tRNA localization studies - To determine the 
intracellular localization of tRNASec we prepared 
mitochondria free of cytosolic RNAs by 
digitonin extraction and subsequent RNase A 
digestion from procyclic T. brucei as described 
(31). RNAs from total cells or isolated 
mitochondria were purified as indicated above 
(29). To test whether tRNASec concentrations 
were different in different life stages of T.
brucei, total RNA of procyclic (strain 427) and 
bloodstream (strain AnTat1.1, a gift from Dr. 
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Seebeck, University of Bern, Switzerland) stages 
of T. brucei was purified. To test whether 
expression of tRNASec is induced in medium 
containing selenium, or under oxidative stress, 
total RNA was isolated from procyclic T. brucei
grown in the absence (0) or the presence of 
0.005 and 0.5 ȝg/ml of added Na2SeO3, or in the 
absence or presence of 10 and 25 ȝMol of added 
H2O2 (data not shown). For all RNA fractions 
the relative expression level of the tRNASec was 
analyzed by Northern hybridization using the 
tRNASec-specific oligonucleotide indicated 
above. The tRNAIle was detected using the 
oligonucleotide
5'TGCTCCCGGCGGGTTCGAA3'.
tRNA preparation - Constructions containing 
a T7 promoter followed by the gene encoding 
wild type or mutated tRNAs were assembled 
using six DNA oligonucleotides that were first 
annealed, and then ligated, between HindIII and 
BamHI restriction sites of plasmid pUC19. In
vitro transcription using T7 RNA polymerase 
was performed according to standard protocols 
(32). Transcripts were separated on denaturing 
PAGE, full-length tRNAs were eluted from gel 
using an electroelution apparatus (Schleicher & 
Schüll) and refolded (2 min at 90 ºC followed by 
a gradual reduction of temperature in presence of 
2.5 mM MgCl2).
Enzyme cloning and purification - The 1.4-
kbp intron-less gene coding for T. cruzi SerRS 
(Tc00.1047053511163.10) was amplified by 
PCR from genomic DNA (strain MC) using Pfu 
Ultra DNA polymerase and cloned in the vector 
pQE-70 for bacterial expression of a C-terminal 
His6-tagged protein. The correct sequence of the 
gene was checked by sequencing it entirely. 
Novablue E. coli cells (Novagen) transformed 
with this construction were grown at 21 ºC up to 
A700nm=0.3. Protein expression was then induced 
with 0.1 mM IPTG during 12 hours. Purification 
on nickel affinity columns was performed using 
standard procedures.
Aminoacylation assays - Aminoacylation 
was performed at 37 ºC in 50 mM Tris-HCl, pH 
7.6, 15 mM MgCl2, 4 mM DTT, 5 mM ATP, 10 
mM NaCl, 100 PM L-[3H] serine (300 Ci/mol) 
and varying concentrations of tRNA transcripts 
(1-80 PM).  Reaction was initiated by addition 
of pure enzyme and samples of 20 Pl were 
spotted onto Whatman 3MM discs at varying 
time intervals (usually 2 min). Radioactivity was 
measured by liquid scintillation. Enzyme 
concentration was experimentally determined for 
each tRNA in order to obtain linear velocities. 
Kinetic constants were obtained from 
Lineweaver-Burk plots using a minimum of  two 
independent measurements and five tRNA 
concentrations.
Phylogenetic and sequence analyses - The 
sequences of seryl-tRNA synthetases used were 
pulled from GENBANK, either directly or by 
BLAST searches of available genomic 
sequences (33). The total set of sequences was 
aligned with CLUSTALX (34). All sequences 
were initially included in our analysis, but were 
later culled to focus our analysis on the 
eukaryotic clade that contains the Trypanosoma
sequences. Coiled-coil predictions were done 
using the programs PAIRCOIL (35), COILS 
(36) and MULTICOIL (37). Phylogenetic 
distributions were calculated by parsimony, 
distance and maximum likelihood methods using 
PHYLIP 3.63 package (38). Maximum 
parsimony analysis (MP) was done using 
PROTPARS. The neighbour-joining method was 
applied using the programs NEIGHBOR and 
PROTDIST, with the Dayhoff 120 substitution 
matrix. Maximum likelihood (ML) phylogenies 
were calculated with the program PROML (38) 
using the JTT substitution matrix. The programs 
SEQBOOT and CONSENSE  (38) were used to 
estimate the confidence limits of branching 
points from 1000 bootstrap replicates in the 
parsimony and distance calculations, while 100 
bootstrap replicates were used for the maximum 
likelihood trees. Several combinations of 
sequences were used in our analyses to test the 
robustness of the trees obtained. All the groups 
of sequences used produced exactly the same 
tree topology reported here. 
RESULTS
RNAi-mediated ablation of the trypanosomal 
SerRS.
To confirm that the putative T. brucei SerRS 
gene encodes the functional enzyme in charge of 
serylation of tRNASer and tRNASec we 
established a stable transgenic cell line, that 
allows tetracycline-inducible RNAi-mediated 
ablation of the protein. This cell line stops 
growing after induction of RNAi, confirming 
that the putative SerRS is essential for normal 
growth of the parasite (Fig. 1A). To determine 
the biochemical phenotype of the RNAi cell line 
we isolated total RNA from untreated cells and 
from cells grown in the presence of tetracycline. 
Subsequently, the RNAs were resolved on long 
acid urea polyacrylamide gels (30) which in 
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combination with Northern analysis allow to 
determine the ratio of charged to uncharged 
tRNASer and tRNASec, respectively. The results 
in Fig. 1B and 1C show that ablation of the 
putative SerRS results in selective accumulation 
of both uncharged tRNASer and uncharged 
tRNASec, indicating that the SerRS identified in 
our study is the enzyme responsible for in vivo
serylation of both of these tRNAs.  
Localization of the tRNASec.
Unlike in other eukaryotes most tRNAs in 
trypanosomatids have a dual localization: 
Approx. 95% are found in the cytosol and 
function in cytosolic translation, however a 
small fraction (approx. 5%) are imported into the 
mitochondrion and function in organelar protein 
synthesis (31). Consequently, trypanosomal 
tRNAs are always encoded in nucleus and never 
on the mitochondrial DNA. T. brucei encodes a 
single selC gene, coding for the tRNASec (24). In 
order to confirm the expression of this tRNA and
to determine its intracellular localization we 
carried out Northern blot analyses using total 
and mitochondrial RNA fractions from procyclic 
T. brucei. The result in Figure 2A shows that the 
tRNASec is only detected in the cytosol but not in 
the mitochondrion. Exclusive cytosolic 
localization is exceptional in trypanosomatids, 
the only cytosol-specific tRNA known to date 
being the initiator tRNAMet (31).
tRNASec expression is not influenced by the life 
cycle stage, selenium or H2O2.
In a next series of Northern blots, we tested 
whether the relative amount of tRNASec when 
compared to other tRNAs was dependent on the 
life cycle stage, or sensitive to the concentration 
of selenium or H2O2 in the culture media. Figure 
2B shows that trypanosomal tRNASec is 
expressed to very similar levels in both the 
procyclic and bloodstream forms of T. brucei.
This suggests that selenocysteine-containing 
proteins play a role throughout the life cycle of T
.brucei. In contrast to reports in vertebrates (39), 
the expression of the tRNASec in procyclic T.
brucei is not affected by the addition of selenium 
to the growth medium (Fig. 2C). A similar result 
was obtained when the parasites were grown in 
the presence of H2O2 (data not shown). 
Characterization of the serylation reaction of 
tRNASer and tRNASec by T. cruzi SerRS .
The cloning of SerRS gene was performed 
directly from genomic DNA. The 54 kDa protein 
was expressed in E. coli, and purified to 
homogeneity by affinity chromatography. Gel 
filtration experiments with the purified enzyme 
confirmed its ability to form dimers (data not 
shown), suggesting that T. cruzi SerRS is a 
classical class II aminoacyl-tRNA synthetase 
(5).
Transcripts of Trypanosoma tRNASer and 
tRNASec were used in aminoacylation assays and 
both were shown to be efficiently aminoacylated 
by SerRS (Fig. 3A). The kinetic constants for the 
serylation of both tRNAs by SerRS were then 
determined (Fig. 3B). The Km for tRNASer of T.
cruzi SerRS was calculated at 3,2 ȝM, a value 
comparable to those found in other systems but 
eight fold higher than that calculated for tRNASec
with the same enzyme. On the other hand, the 
Kcat was essentially identical to that calculated 
for tRNASec. As a result, the Kcat/Km value for 
Trypanosoma tRNASer is seven fold lower than 
that of T. cruzi tRNASec. Interestingly, these 
values are markedly different from those 
reported in other species. Thus, in the human 
system (25), the serylation of tRNASec is 10 fold 
less efficient than that for tRNASer, and this 
difference grows to a 100 fold in favour of 
tRNASer in E. coli (26) (Fig. 3C). 
Identity determinants in the acceptor stem of 
tRNASer.
To understand how T. cruzi SerRS recognizes 
its cognate tRNAs, mutants of tRNASerCGA were 
produced and their ability to be charged with 
serine was measured in vitro in presence of 
purified SerRS. Fourteen tRNA variants were 
generated, covering nearly 80 % of the primary 
structure. The design of the mutations was 
dictated both by the sequence conservation 
among T. cruzi tRNASer and tRNASec sequences 
(Fig. 4A), and by the distribution of identity 
elements in homologous tRNASer sets. A set of 
modifications targeted individual nucleotides or 
base pairs in the acceptor stem (variants 1 to 9) 
(Fig. 4B), whereas a second set of changes 
introduced large deletions or sequence swaps of 
discrete tRNA domains (variants 10 to 14) (Fig. 
4C).
The change of the discriminator base G73 for 
pyrimidines had a dramatic effect on the 
charging of tRNASer (mutants 1 and 2) (Table 1), 
indicating that the enzyme strongly recognizes 
this position of the acceptor stem. This 
sensitivity to the discriminator base sequence is 
reminiscent of the recognition mechanisms 
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described for H. sapiens and archaeal SerRSs 
(17-19).
The first base pair (1:72) was found to be the 
most sensitive position in the acceptor stem of 
tRNASer. Indeed, the simple inversion of the 
G1:C72 base pair (mutant 4) completely 
abolished the aminoacylation of this substrate by 
the enzyme. The introduction of a G1:U72 base 
pair in the tRNASer scaffold had no effect on the 
ability of this tRNA to be charged by SerRS 
(mutant 5), indicating that G1 may be 
contributing important contacts to the 
recognition by SerRS (Table 1).  It should be 
noted that both the discriminator base G73 and 
the G1 base found to be essential for recognition 
of tRNASer by Trypanosoma SerRS are 
conserved in the sequences of tRNASec of the 
same species. 
Additional mutations in other regions of the 
acceptor stem had no significant effect on the 
overall recognition of tRNASer by T. cruzi SerRS 
(mutant 6 to 9). Overall, our acceptor stem 
mutations affect mostly Kcat values, suggesting a 
defect in the reactive positioning of the acceptor 
extremity rather than a loss in binding energy.  
Identity determinants beyond the acceptor stem 
of tRNASer.
Next, we wanted to investigate the 
importance of the pseudoknot (D arm, T arm and 
variable loop)  and anticodon domains of T.
cruzi tRNASer for its recognition by SerRS. The 
three domains of the tRNA that form the 
pseudoknot were individually flipped (mutants 
11 to 13) in order to vary their sequences 
without modifying the local secondary structure 
or the strength of their internal base pairs (Fig. 
4C). None of the three corresponding mutants 
showed any catalytic defect, suggesting that the 
recognition mechanism for the elbow of the 
tRNA is based exclusively on interactions with 
the sugar-phosphate backbone (Table 1).
To further test this hypothesis the entire 
variable loop was excised, and replaced by the 
most commonly found class I variable loop 
(mutant 14) (Fig. 4C). This replacement had a 
dramatic effect on aminoacylation, causing a 
>8000 fold drop in Kcat/Km. This mutation 
affected both catalytic and affinity constants. 
Our combined data indicates that this domain is 
recognized in a sequence-unspecific manner, 
provides binding energy, and acts as a guide for 
the reactive positioning of the tRNA (Table 1).
Finally, the entire anticodon loop was deleted 
and replaced by a stretch of four uridines 
(mutant 10) (Fig. 4C). This linker was used 
because it is the least likely to stabilize 
unanticipated structures in this region of the 
tRNA (13). This deletion mutant had only a 
modest effect on the velocity of the 
aminoacylation reaction. This is in agreement 
with other studies that have shown that the 
anticodon domain of eukaryotic tRNASer
contributes poorly to the serine identity (for a 
review see (11)) (Table 1).
Phylogeny of Trypanosoma SerRS. 
The known genomes of Trypanosoma code 
for only one SerRS gene. The corresponding 
protein is likely used both in the cytoplasm and 
the mitochondria, but no conventional targeting 
sequence can be identified in their sequences. 
The protein is 477 amino acids long, and it 
contains an N-terminal domain predicted to form 
a coiled coil domain (36), as seen in the 
available structural data for homologous 
enzymes (16, 40). 
Multiple sequence alignments readily show 
the presence of a large synapomorphy that 
clusters trypanosomatid SerRSs with the rest of 
metazoan sequences (Fig. 5A). This 
synapomorphy is an insertion of twenty amino 
acids located at the center of the N-terminal 
coiled-coil motif of this group of SerRSs (Fig. 
5B). Coiled-coil prediction of this group of 
sequences suggest that in metazoans  and 
trypanosomatids this region may extend beyond 
the length seen in the structures solved so far 
(data not shown). 
Our phylogenetic analysis of SerRS 
sequences is the first one of this enzyme to 
include kinetoplastid sequences. When 
sequences from all life domains were used, our 
results consistently agreed with previous 
analyses (41-44), supporting the conclusion that 
the overall evolution of this enzyme conforms to 
the canonical phylogenetic tree derived from 
ribosomal RNA sequences (Fig. 6A) (41,43). 
Although we were unable to obtain significant 
bootstrap support for the central branching 
points of the general tree, the trypanosomatid 
sequences strongly associated with metazoan 
sequences with strong bootstrap support, both in 
general trees and those limited to the major 
eukaryotic lineages  (Fig. 6A and 6B). It should 
be stressed here that the region corresponding to 
the synapomorphy that also links Trypanosoma
sequences with metazoan ones was not used in 
our phylogenetic analyses. 
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DISCUSSION
The constraints acting over tRNA recognition 
are strictly intra-specific and, for each species 
constitute a complex set of recognition and 
rejection elements that ensures faithful 
translation (45). Possibly this complex set of 
positive and negative identity elements 
contributes to the stability of the genetic code 
and limits its size, because the incorporation of 
new amino acids would require an increase in 
complexity of the recognition problem which 
may be impossible to assume without increasing 
the rate of aminoacylation errors (3). 
In order to study the evolution of these sets of 
recognition elements we decided to characterize 
the recognition of tRNASer and tRNASec by 
Trypanosoma SerRS. In doing so we were 
expecting to extract information about the 
evolution of this recognition mechanism in the 
basal part of the eukaryotic phylogenetic tree. 
For convenience we chose Trypanosoma brucei
as a model for the in vivo studies, while the in
vitro studies were performed with Trypanosoma
cruzi proteins and tRNAs. The overall identity 
between T. cruzi and T. brucei SerRSs is 80 %, 
and the sequences of their tRNASer are 
essentially identical. 
 We have shown that Trypanosoma SerRS
recognizes its cognate tRNAs using a 
combination of structural signals in the variable 
loop and the sequence information of the 
discriminator base and the first base pair of the 
acceptor stem. The discriminator base G73 and 
the G1 base are essential for recognition by 
Trypanosoma SerRS. These bases are conserved 
among all serine tRNA isoacceptors in 
Trypanosoma, and strongly influence the 
velocity of the serylation reaction.  
Previous studies on tRNASer recognition in 
the three kingdoms of life show that acceptor 
stem recognition by SerRS fluctuates between 
the first four base pairs and the discriminator 
base of the acceptor stem (17, 46, 47). In the 
case of Trypanosoma, this recognition has 
shifted towards the CCA end of the molecule, 
and the discriminator base and the first base pair 
constitute the region recognized by SerRS. 
We have established that the presence of a 
long variable loop is a pre-requisite to tRNASer
recognition, but that this mechanism is not 
sequence specific. Moreover, the complete 
deletion of tRNASer anticodon domain does not 
affect its serylation by SerRS, confirming that 
the entire stem and anticodon loop is ignored by 
the enzyme during the recognition process. This 
feature is common to all serine systems studied 
so far with the only exception of M. barkeri
SerRS, which displays a strong interaction with 
the G30:C40 base pair in the anticodon stem 
(46).
In summary, our data suggest that the tRNA 
specificity of Trypanosoma SerRS relies on a 
two-pronged mechanism based on interactions 
with the G73 discriminator base and the G1 base 
on one side, and the sequence-independent 
recognition of the variable loop on the other. 
Interestingly, this recognition mechanism 
functionally associates trypanosomatid SerRSs 
with their metazoan homologs, and separates 
them from other eukaryotic enzymes such as S.
cerevisiae SerRS. This functional relationships 
are in agreement with the phylogenetic 
connections that we report here, and the 
presence of clear sequence synapomorphies that 
link these enzymes evolutionarily.  
A possible explanation to this functional 
convergence would be a lateral gene transfer 
event between trypanosomatids and metazoans 
that could be favored by the parasitic nature of 
the former. A second possibility, more in 
agreement with polyphiletic  views of eukaryote 
evolution (4), would be that the recognition 
solution displayed by metazoans and 
trypanosomatids is ancient, having persisted in 
these two groups of organisms since their 
radiation at the base of the eukaryotic 
evolutionary tree.  Our phylogenetic studies do 
not allow us to discard either possibility. 
Another interesting feature of trypanosomatid 
SerRSs is their apparently high affinity for 
tRNASec. Indeed, the Kcat/Km value for the 
aminoacylation of Trypanosoma tRNASer (which 
are comparable to values established for other 
species) is seven fold lower than that found for 
T. cruzi tRNASec, a result that is in direct contrast 
with the values reported for the human system 
(25) (where the tRNASer is 10 fold more 
efficiently charged than tRNASec) or in 
Escherichia coli  (26) (100 fold difference in 
favour of tRNASer) (Fig. 3B).
It should be noted here that all the studies 
where these values are reported (including this 
one) were performed with transcript tRNAs, thus 
excluding the potential effect of base 
modifications in either substrate. However, there 
seems to be a clear difference between the 
relative aminoacylation of tRNASec and tRNASer
between trypanosomatids and other species. This 
may be explained by a high requirement for 
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selenoprotein synthesis in these species. Our 
attempts to increase the levels of tRNASec in T.
brucei by the presence of oxidative stress or 
different growth conditions were unsuccessful, 
but these results are not necessarily 
contradictory with a high level of selenocysteine 
use by these organisms. 
From our studies it is clear that tRNASec is 
not imported into the mitochondria of T. brucei.
Some of us have recently shown that tRNA 
localization signals in this species are confined 
to two nucleotide pairs in the T-stem (48). In the 
cytosol-specific initiator tRNAMet these positions 
include the anti-determinants that, based on 
experiments with vertebrate initiator tRNAMet
(49), are predicted to prevent interaction with 
translation elongation factor 1a (eEF-1a). The T-
stem sequence of the cytosolic tRNASec is 
different to all other T. brucei tRNAs including 
the cytosolic initiator tRNAMet. However, a 
feature that is shared between the two cytosol-
specific tRNAs in T. brucei is that neither 
interacts with eEF-1a. Instead, the initiator 
tRNAMet interacts with initiation factor 2, and the 
tRNASec with the specialized elongation factor 
SelB/EFsec.
Thus, while the structural determinants that 
prevent interaction with EF-1a are different for 
both tRNAs, the mechanism for cytosolic 
localization might in both cases be achieved by 
exclusion of EF-1a binding. In other words, all 
tRNAs that interact with eEF-1a might be 
imported into mitochondria, and the ones which 
do not remain in the cytosol. 
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FIGURE LEGENDS 
Fig. 1. SerRS is essential for growth of procyclic T. brucei and is responsible for the serylation of both 
tRNASer and tRNASec. (A) Growth curve in the presence and absence of tetracycline (+, -Tet) of a 
representative clonal T. brucei RNAi cell line ablated for the trypanosomal SerRS homologue. (B) 
Northern blot analysis of total RNA isolated under acidic conditions from the SerRS RNAi cell line. 
Hours of induction by tetracycline are indicated at the top. The blots were probed for the T. brucei
tRNASer  and tRNAIle. The latter serves as controls that is not affected by the RNAi. The RNA 
fractions were resolved on long acid urea gels that allow to separate aminoacylated (aa) from 
deacylated (dea) tRNAs. The relative amounts of deacylated tRNASer and tRNAIle are indicated at the 
bottom. For each lane the sum of aminoacylated and deacylated tRNA was set to 100% percent. (C) 
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Same as (B) but analysis was done for the tRNASec. The x refers to an unidentified band probably 
corresponding to phosphoserine.
Fig. 2. Expression of tRNASec in T. brucei. (A) tRNASec is not imported into the mitochondrion. Left 
panel: 0.1 x 108 cell equivalents of total (Tot.) and 2 x 108 cell equivalents of mitochondrial (Mito.) 
RNA, isolated by digitonin extraction from procyclic T. brucei, were separated on a 10% 
polyacrylamide/8 M urea gel and stained with ethidium bromide. Right panel: the gel was processed 
for Northern hybridization and probed for tRNASec and imported tRNAIle. (B) tRNASec is expressed in 
both life cycle stages. Total RNA, 5 and 7 ȝg each, of procyclic (Proc.) and bloodstream stage T.
brucei was analyzed by Northern hybridization as in (A). The relative expression levels (set to be 1 for 
procyclic RNA) of the tRNASec when compared to the expression of tRNAIle are indicated at the 
bottom. (C) Expression of tRNASec is not induced in medium containing selenium. Five ȝg of total 
RNA isolated from procyclic T. brucei grown in the absence (0) or the presence of 0.005 and 0.5 
ȝg/ml of added Na2SeO3 were analyzed by Northern hybridization as in (A) and (B). The relative 
expression levels are indicated. 
Fig. 3. Comparison of charging efficiency of tRNASec and tRNASer from various origins. (A) 
Aminoacylation plot of trypanosomal tRNASer (Ŷ) and tRNASec (i) in the presence of purified seryl-
tRNA synthetase and [3H] serine. Three independent measures have shown only minimal variations of 
the charging activity, ranging from 1 to 15% (data not shown on the graph for visual clarity). (B) 
Comparison of the kinetic values for the in vitro serylation of trypanosomal, human and E. coli
transcribed tRNASer and tRNASec (25, 26, this work).  N.D., not determined (C) Histogram showing 
the efficiency of aminoacylation of tRNASec with respect to tRNASer for T. cruzi, H. sapiens, and E.
coli. The level of aminoacylation efficiency of tRNASer is indicated by a dashed line. The gray 
columns represents the level of aminoacylation efficiency of tRNASec. T. cruzi tRNASec is 7 fold more 
efficiently aminoacylated than T. cruzi tRNASer. * The data concerning E. coli tRNASer and tRNASec
were reported from experiments using total protein extract as the source of SerRS (26).
Fig. 4. Secondary structure of tRNASerCGA and its mutants. (A) The cloverleaf structure of tRNASerCGA
is presented. The circles denote nucleotides conserved among the four T. cruzi tRNASer isoacceptors. 
The squares denote nucleotides conserved both in tRNASer and tRNASec. (B) Detail of the mutations 
performed on the acceptor stem of tRNASerCGA. Each mutant is labeled in parenthesis. (C) Detail of the 
mutation performed beyond the acceptor stem. Curved arrows and dashed lines are used to denote the 
flipping, and the deletion of sequences, respectively.  
Fig. 5. Sequence alignment of the region of SerRS sequences that contains the synapomorphy that 
links metazoan and trypanosomatid enzymes. (A) The alignment was performed using CLUSTAL X 
(34). T. cruzi and T. brucei SerRS sequences are in bold. Helix 1 and helix 2 indicate the long helices 
that form the coiled-coil arm found in T. thermophilus SerRS. The insertion that is present in metazoan 
and trypanosomatid sequences is boxed and labeled accordingly. (B) Crystallographic structure of one 
monomer of T. thermophilus SerRS (16). The coiled-coil arm important for the stabilization of the 
tRNASer pseudoknot is highlighted in green. The apparent insertion point of the metazoan and 
trypanosomatid synapomorphy is marked by an arrow and labeled accordingly.  
Fig. 6. Phylogenetic analysis of trypanosomal SerRS. 
(A) Maximum likelihood tree of archaeal, bacterial, and eukaryotic seryl-tRNA synthetase sequences. 
The overall architecture of  this tree was obtained with all methods used, but bootstrap support was 
weak (not shown). (B) Consensus tree of eukaryotic seryl-tRNA synthetase sequences. The association 
between trypanosomatid and metazoan SerRSs is highlighted. Numbers correspond to percentages of 
bootstrap support for each node from the parsimony, distance, and ML analyses. 
Table 1. Serylation parameters of tRNASec, tRNASer and its variants in presence of SerRS. The rate of
aminoacylation of the wild type tRNASer is 9.56 s-1. For better readability the kcat of each mutant is 
expressed as a percentage of the kcat value of the wild type tRNASer (i.e. a rate of 9.56 s-1 corresponds 
to a kcat of 100%). The overall efficiency of serylation has been determined as the ratio between the 
Km and the kcat. To enhance the readability the efficiency of the wild type tRNASer have been set at 1. 
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Values higher than 1 denote tRNA variants that are less efficiently aminoacylated and vice versa.
Numbers in parentheses refers to the mutations detailed on figure 4B and 4C. 
ĮND, not determined 
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Figure 1
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Figure 2
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Figure 3
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Figure 5
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Figure 6
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Table 1
Transcripts kcat (%) Km (PM) rel Km/kcat 
Wild-type tRNASerCGA 100 3.2 1 
Wild-type tRNASecUCA 91 0.4 0.1 
G73oA (1) 16 4.7 9.1 
G73oC (2) 1 13 416.6 
G73oU (3) 0.01 Įnd Įnd
G1:C72oC:G (4) <0.001 Įnd Įnd
G1:C72oG:U (5) 89 2.0 0.7 
U2:A71oA:U (6) 82 0.9 0.3 
U2:A71oG:C (7) 165 4 0.7 
U2:A71oU:G (8) 114 2.6 0.7 
C3:G70oG:C (9) 56 5.6 3.1 
' anticodon domain (10) 15 2.5 5.3 
D arm Flip (11) 152 3.5 0.7 
T arm Flip (12) 101 3.9 1.2 
Variable loop Flip (13) 85 6.4 2.4 
' variable loop (14) 0.25 71 8 928 
